Successful pregnancy in a cancer patient previously cured of a gestational trophoblastic tumor by immunotherapy

P-A Bolze; B You; J-P Lotz; J Massardier; L Gladieff; F Joly; T Hajri; D Maucort-Boulch; S Bin; A Roux; P Rousset; L Villeneuve; M Alves-Ferreira; D Grazziotin-Soares; C Mercier; G Freyer; F Golfier

doi:10.1016/j.annonc.2020.02.015

Successful pregnancy in a cancer patient previously cured of a gestational trophoblastic tumor by immunotherapy

Ann Oncol. 2020 Jun;31(6):823-825. doi: 10.1016/j.annonc.2020.02.015. Epub 2020 Mar 11.

Authors

P-A Bolze¹, B You², J-P Lotz³, J Massardier⁴, L Gladieff⁵, F Joly⁶, T Hajri⁷, D Maucort-Boulch⁸, S Bin⁹, A Roux¹⁰, P Rousset¹¹, L Villeneuve⁹, M Alves-Ferreira⁹, D Grazziotin-Soares³, C Mercier¹², G Freyer¹³, F Golfier¹⁴

Affiliations

¹ French Reference Center for Trophoblastic Diseases, Lyon, France; Faculty of Medicine Lyon-Sud, Claude Bernard University Lyon 1, EMR UCBL/HCL 3738, University of Lyon, Lyon; Gynecological Oncological, and Obstetrics Department, Lyon-Sud Hospital, Hospices Civils de Lyon, Lyon, France. Electronic address: [email protected].
² French Reference Center for Trophoblastic Diseases, Lyon, France; Faculty of Medicine Lyon-Sud, Claude Bernard University Lyon 1, EMR UCBL/HCL 3738, University of Lyon, Lyon; Department of Medical Oncology, Cancerology Institute of Hospices Civils de Lyon (IC-HCL), CITOHL, Lyon-Sud Hospital, Lyon, France.
³ French Reference Center for Trophoblastic Diseases, Lyon, France; Department of Medical Oncology, Tenon Hospital, Sorbonne University, Paris, France.
⁴ French Reference Center for Trophoblastic Diseases, Lyon, France; Gynecology and Obstetrics Department, Prenatal Diagnosis Unit, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Bron, France.
⁵ Oncology Department, Institut Universitaire du Cancer Toulousain (IUCT) Oncopole, Institut Claudius Regaud, Toulouse, France.
⁶ UNICANCER, Cancer Center F. Baclesse, Medical Oncology Department and Clinical Research Unit, Caen, France.
⁷ French Reference Center for Trophoblastic Diseases, Lyon, France.
⁸ Faculty of Medicine Lyon-Sud, Claude Bernard University Lyon 1, EMR UCBL/HCL 3738, University of Lyon, Lyon; Biostatistics Department, Hospices Civils de Lyon, Lyon-Sud Hospital, Lyon, France; Claude Bernard University Lyon 1, Lyon, France; CNRS UMR5558, Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique-Santé, Villeurbanne, France.
⁹ Unité Recherche et Epidémiologie Cliniques - Pôle de Santé Publique, Lyon-Sud Hospital, Hospices Civils de Lyon, Lyon, France.
¹⁰ Service des Données de Santé - Pôle de Santé Publique, Lyon, France.
¹¹ Faculty of Medicine Lyon-Sud, Claude Bernard University Lyon 1, EMR UCBL/HCL 3738, University of Lyon, Lyon; Department of Radiology, Lyon-Sud Hospital, Hospices Civils de Lyon, Lyon, France.
¹² Biostatistics Department, Hospices Civils de Lyon, Lyon-Sud Hospital, Lyon, France; Claude Bernard University Lyon 1, Lyon, France; CNRS UMR5558, Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique-Santé, Villeurbanne, France.
¹³ Faculty of Medicine Lyon-Sud, Claude Bernard University Lyon 1, EMR UCBL/HCL 3738, University of Lyon, Lyon; Department of Medical Oncology, Cancerology Institute of Hospices Civils de Lyon (IC-HCL), CITOHL, Lyon-Sud Hospital, Lyon, France.
¹⁴ French Reference Center for Trophoblastic Diseases, Lyon, France; Faculty of Medicine Lyon-Sud, Claude Bernard University Lyon 1, EMR UCBL/HCL 3738, University of Lyon, Lyon; Gynecological Oncological, and Obstetrics Department, Lyon-Sud Hospital, Hospices Civils de Lyon, Lyon, France.

PMID: 32171750
DOI: 10.1016/j.annonc.2020.02.015

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Female
Gestational Trophoblastic Disease* / drug therapy
Humans
Immunotherapy
Neoplasms*
Pregnancy
Uterine Neoplasms* / therapy